One of the Leading Players in China's Insurance Industry
Ping An Insurance Group (HKEX.2318) is China’s second largest life insurer in terms of total written premiums. It is also the second largest property and casualty (P&C) insurer in the country. Founded 30 years ago, the traditional insurance company has since evolved into a sprawling digital financial platform, offering a wide variety of financial products and services such as loans, wealth management, insurance, cars, property and healthcare.
Unlike other major insurers who are pure-plays in either life or non-life insurance, Ping An operates in both segments. Ping An’s revenue is derived from five major segments: Life Insurance, P&C Insurance, Banking, Asset Management, and Other Financial Services (Chart 1), with 75% of revenue from its insurance business. Ping An leads the Chinese insurance industry by revenue and profitability. Its total market capitalisation, at USD 157.5 billion, is 80% larger than China’s old standard, China Life Insurance (HKEX.2628).
Chart 1: Ping An Derived Majority of 2017 Revenue from Its Insurance Segments

1. Ample Room For Growth In China’s Insurance Industry
The demand for insurance (both life and non-life) in China has been ascending rapidly in recent years. China’s insurance premiums grew at a CAGR of 20.1% in the last ten years to a total of RMB 3.1 trillion in 2016 (Chart 2). Accounting for about 10% of world’s total premium, China is the second largest insurance market in the world. However, despite its size, the percentage of policyholders in the Chinese populace remains low. .
Chart 2: China’s Rising Insurance Market and Insurance Penetration from 2000-2016

Thanks to its underpenetrated insurance market, China has ample room for growth. As of 2016, China’s total insurance penetration rate (defined as premiums as percentage of GDP) of 4.1% is still well below the global developed markets’ average of 8% (Chart 3). This means that, the insurance industry in the world’s most populous nation has the potential to double in size, as its penetration rate converges to that of the developed markets’ average. Thus, we are positive that the immense growth potential of China’s insurance market will provide lucrative opportunities for insurers like Ping An.
Chart 3: China’s Insurance Industry is Underpenetrated Compared to Various Markets in 2016

2. Strong Demographic Trends Driving Insurance Demand
This positive outlook for China’s insurance industry is also reinforced by strong demographic trends such an ageing population and growing disposable income.
Firstly, the fast ageing Chinese population is creating strong demand for retirement-related insurance products. Coupled with falling birth rates (a result of rapid urbanisation and higher living costs), China has seen its dependency ratio (percentage of senior population against country’s labour force) accelerating in the last 5 years. While the recent demographic trends are a growing cause for concern, insurance companies will benefit as the troubling statistics will prompt many to plan ahead for their retirement years, driving up demand for health policies and annuities.
Chart 4: China’s Aging Population and Rapidly Accelerating Elderly Dependency Ratio

Secondly, China’s increasingly wealthy population and expanding middle class are also driving greater demand for insurance products. China’s per-capita disposable income expanded by a CAGR of 10% over the past 10 years. Over the same period, insurance premiums grew at a much faster CAGR of 20% (Chart 5). As Chinese families become wealthier, demand for wealth management products for capital preservation will grow rapidly.
The rising affluence is also fuelling higher consumer spending in automobiles, tourism, home purchases, which in turn will ramp up demand and sales of auto, travel and home insurance. With the Chinese middle class expected to almost double from the current 430 million to 780 million by mid-2020s, there is going to be more wealth to protect and even more demand for P&C coverage.
Chart 5: China’s Insurance Premiums per Capita Rising Alongside Disposable Income Per Capita

3. Favourable Operating Conditions for Ping An
Faced with mounting government debt and the ascending elderly dependency ratio, China’s pension shortfall is also emerging as a next big challenge for the government. As state support for the ageing population gradually erodes, we expect the Chinese government to increasingly turn towards insurers to help fill the gap in public provision. This will likely benefit larger and more reputable insurers like Ping An.
At the same time, the rising interest rate environment in China continue to bode well for China’s insurers. With increased efforts by the China government to deleverage its economy through a series of interest rate hikes, bond yields has been rising in China in the past two years. Since insurers derive investment income from the interest generated by their bond portfolios, the rising interest rates will effectively translate into higher investment income for China’s insurers, whose share prices historically move in tandem with interest rates. (Chart 6).
While China’s 10-year bond yields has declined slightly in recent months, we are positive that the Chinese government remains committed to improving the health of its economy through deleveraging and tightening policies.
Chart 6: Ping An Share Price Mirror Closely to Movements of China 10-Year Bond Yield

4. Digital Distribution A Future Growth Driver
As a first-mover in insurance e-commerce (or Insurtech), Ping An’s intuitive digital platform has increased the ease of access for customers who wish to purchase their life and non-life (mainly auto) insurance online at their own comfort. Its digital outreach has proved successful, having acquired more than 18 million new customers from its internet portals alone just last year – accounting for 40% of new customers in 2017. Online insurance also enables Ping An to process claims submitted digitally, reducing the hassle of physical paperwork typically required on both users and company.
Moving forward, digital distribution of insurance, especially health, is becoming all the more important. According to Oliver Wyman, the size of health-related online insurance is expected to grow to RMB 198 billion by 2021, representing a CAGR of 45.9% (Chart 7). The percentage of the overall health insurance market that is addressable by online distribution is expected to increase from 7% in 2016 to 22% in 2021. More than just health, other insurance categories like travel and auto are also experiencing similar trends, projected to grow at CAGR of 27.1% and 51.1% respectively.
As Chinese consumers purchase more insurance online, we are positive that Ping An’s rapidly expanding online insurance sales will increasingly contribute to a greater portion of the company’s top line, given its prominent digital presence.
Chart 7: Explosive Growth of China Online Insurance Industry in the Next Few Years

5. Strategic Investments in Financial and Health Technology Starting To Bear Fruit
Ping An’s strategic technological investments in financial technology (Fintech) and health technology (Healthtech) are fast becoming the group’s next important profit generator. This segment brought in RMB 14.6 billion for the group in 2017, contributing to 16% of net profits. We believe Ping An’s series of technological entities will provide greater diversification of its revenue stream, as well as bringing it closer to its vision of creating an integrated ecosystem for personal financial services.
Ping An has two exciting Fintech and Healthtech investments worth highlighting:
Lufax is China’s largest online wealth management and Peer-to-Peer (P2P) lending platform. With China’s P2P loans standing at RMB 1.2 trillion last year, growing at a CAGR of 128% in 2014-17, we think Lufax is well-positioned to benefit from this huge growth potential. It is also worth noting that Lufax recognised profit for the first time last year. The potential IPO of Lufax would provide the Group with huge one-off gain potential.
Ping An Good Doctor (HKEX.1833) is one of China’s largest online medical platform. The market-leading platform provides a wide range of services, including preliminary inquities, hospital registrations and drug purchases. The mobile application currently boasts 180 million registered user and 5 million daily active users – five times larger than its closest competitors (WeDoctor and HaoDaifu). With China’s aging population and ever-growing middle class, the huge demand for medical services is set to outpace supply. We are positive PAGD will thrive through its dominant position in China’s rapid growing internet healthcare industry.
Investment Risks
A. Reversal In The Interest Rate Upcycle
Since a portion of revenue (11%) from Ping An’s insurance business is derived from investment income, a sudden decline in bond yields will lead to a fall in revenue from the segment. Its banking operations will also be negatively impacted by the falling net interest margins. However, we believe that the likelihood of this scenario is rather low, considering that the China government has repeatedly expressed conviction on reducing financial risks in its economy.
B. Slower-Than-Expected Economic Growth
A slowdown in the Chinese economy will result in a softer demand for insurance products, which translates to a drop-off in new business value created, all of which will negatively impact both the top-line and bottom-line of Ping An insurance business. However, we are positive that the growth in the world’s second largest economy remains robust and any potential slowdown in the growth of Chinese economy is likely to be minimal.
Fair Valuations
Using a Sum-Of-The-Parts (SOTP) approach, we value Ping An Insurance Group at HKD 99.80 per share. Based on its closing price of HKD 70.40 (as of 11-July-18), this implies an upside potential of 41.7%. The calculations for the SOTP valuation are tabulated in Table 1 below.
Table 1: Sum-Of-The-Parts Valuation of Ping An Insurance Group
Business Segment |
Method |
Multiple |
Per Share (HKD) |
Life Insurance |
Historical P/EV |
2X |
75.78 |
Non-Life Insurance |
Peers P/B |
2.3X |
12.64 |
Banking |
Peers P/B |
0.65X |
6.41 |
Securities |
Peers P/B |
7.5X |
1.05 |
Other Businesses |
Book Value |
1X |
2.38 |
Lufax |
Book Value |
1X |
0.35 |
Good Doctor |
Market Cap |
- |
1.21 |
Total Per Share |
99.80 |
||
Source: Bloomberg, Consensus Estimates, iFAST Estimates. |
|||
Our assumptions include:
Table 2: Peers Comparison - Ping An Has Highest Return on Equity
China Insurers |
Ticker Code |
FY18E PE (X) |
FY18E PB (X) |
FY18E ROE (%) |
Ping An |
HKEX.2318 |
15.2 |
2.8 |
19.3 |
Life Insurers |
||||
China Life |
HKEX.2628 |
16.0 |
1.9 |
12.7 |
China Pacific |
HKEX.2601 |
17.6 |
2.3 |
13.8 |
New China Life |
HKEX.1336 |
15.8 |
1.8 |
10.7 |
China Taiping |
HKEX.966 |
15.9 |
1.7 |
11.2 |
Average |
- |
16.3 |
1.9 |
12 |
P&C Insurers |
||||
PICC P&C |
HKEX.2328 |
9.3 |
1.3 |
15.4 |
ZhongAn P&C |
HKEX.6060 |
- |
4.6 |
0.86 |
Average |
- |
9.3 |
2.3 |
8.2 |
Source: Bloomberg, Consensus Estimates, iFAST Estimates. |
||||
Ping An: Undervalued Insurance Titan with Strong Growth Potential
Ping An’s emphasis on technology to drive growth has synergised with its traditional financial business, boosting its value and competitiveness to differentiate itself from other financial service companies. In the face of a booming insurance industry, we believe that Ping An is well-positioned to thrive and expand strongly in the next 3-5 years.
Overall, we see Ping An Insurance Group as a solid choice for exposure to the Chinese insurance industry.
Take Your Portfolio To The Next Level With This Exciting Promotion!
Here’s a piece of good news for FSMOne investors: we have extended our promotion for FREE LIVE STREAMING when you trade in HKEX Stocks/ETFs. So hurry up and take advantage of this fabulous offer before it ends! While you're at it, we've also put together an ETF Focus List that will certainly help in your portfolio construction process.
(Related Article: *Extended* Promotion: FREE LIVE STREAMING When You Trade in HKEX Stocks/ETFs)Declaration:
For specific disclosure, at the time of publication of this report, IFPL (via its connected and associated entities) and the analyst who produced this report hold a NIL position in the abovementioned securities.
All materials and contents found in this site are strictly for general circulation and informational purposes only and should not be considered as an offer, or solicitation, to deal in any of the funds or products found/identified in this site. While iFAST Financial Pte Ltd ("IFPL") has tried to provide accurate and timely information, there may be inadvertent delays, omissions, technical or factual inaccuracies and typographical errors. Any opinion or estimate contained in this report is made on a general basis and neither IFPL nor any of its servants or agents have given any consideration to nor have they or any of them made any investigation of the investment objective, financial situation or particular need of any user or reader, any specific person or group of persons. You should consider carefully if the products you are going to purchase are suitable for your investment objective, investment experience, risk tolerance and other personal circumstances. If you are uncertain about the suitability of the investment product, please seek advice from a financial adviser, before making a decision to purchase the investment product. Past performance is not indicative of future performance. The value of the investment products and the income from them may fall as well as rise. Opinions expressed herein are subject to change without notice. In respect of any matters arising from, or in connection with the said research analyses or research reports, recipients of the report are to contact IFPL at 10 Collyer Quay, #26-01 Ocean Financial Centre Building, Singapore 049315, or by telephone at +65 6557 2853. Where the report contains research analyses or research reports from a foreign research house and if the recipient of such research analyses or research reports is not an accredited investor, expert investor, institutional investor or an ex-accredited investor, IFPL accepts legal responsibility for the contents of such analyses or reports to such persons only to the extent as required by law. Please note that only certain security(ies) herein are available to all investors, while the rest are only available for certain persons to invest in, such as Accredited Investors (as defined in the Securities and Futures Act) or one who invests at least S$200,000 (or its equivalent currency) per transaction. To qualify as an Accredited Investor, one needs to submit a declaration form and certain relevant supporting documents, according to iFAST’s prevailing policies and procedures.
Please read our full disclaimers on the website at ( https://secure.fundsupermart.com/fsmone/policies/328125/investment-account-terms-&-conditions).
iFAST Financial Pte Ltd (IFPL) (registered address: 10 Collyer Quay #26-01 Ocean Financial Centre Singapore 049315, Telephone: 6557 2000) holds the Financial Advisers Licence issued by the Monetary Authority of Singapore ('MAS') to conduct regulated activities of advising on securities, marketing of collective investment schemes and arranging of any contract of insurance in respect of life policies, other than a contract of reinsurance and the Capital Markets Services Licence issued by the MAS to conduct regulated activities of dealing in securities and providing custodial services for securities. While IFPL has made every effort to ensure the independence of the report's contents, IFPL's nature of business is such that IFPL and its connected and associated entities together with their respective directors, officers and staff may be involved in providing dealing or investment-related services in the abovementioned securities, and have taken or may take positions in the securities mentioned in this report, and may also act as the principal for any buy or sell trades.
